The criterion for acceptance of presentation at the CRS Annual Meeting and Exposition is based on an anonymous peer-review process. The author must obtain the necessary permissions prior to submission of the abstract.
The CRS Annual Meeting Program Committee reserves the right to evaluate, accept, or reject any submitted abstract. The committee will determine the status (accept or reject) of all submitted abstracts and the placement (podium or poster) of all accepted abstracts. The committee may also switch abstracts to any topic category based on their evaluation and organization requirements. Remember:
- Abstract should fit within one of the scientific topics (must choose one)
- Remember to edit and proof your abstract before submitting. Early submissions are encouraged to avoid delays on the last day
- Abstract must be written in clear English
- Abstract must be two pages (See Model Abstract)
- If not all data (example: active compound used) can be disclosed due to confidentiality, the abstract will not be rejected immediately; however, the reviewers will decide whether or not it contains enough interesting insights for acceptance.
If the abstract is accepted, the designated presenting author must register by May 1, 2014, for the 41st CRS annual meeting, July 13-16, 2014, in Chicago, Illinois, U.S.A., and must agree to present the abstract at the annual meeting. If the designated presenting author is not registered, the abstract will be withdrawn and will not be included in the program or 41st Annual Meeting Transactions Online. If you do not present your podium abstract or if your poster abstract is not displayed during the designated poster times your abstract will be removed from Transactions Online.
The submitter confirms that the abstract is an original work and has not been previously published. The submitter and any contributing authors, as sole proprietors of the abstract, agree to transfer copyright of the abstract to the Controlled Release Society. Abstracts will be published online on June 13, 2014. By agreeing, the submitter accepts the copyright transfer. Failure to accept the copyright transfer will result in the immediate cancellation of the abstract submission.
Notification of acceptance will be e-mailed in April to the presenter only.